Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans

Journal of the National Cancer Institute

Volumn 99, Issue 20, 2007, Pages 1525-1533

  Zheng, S Lilly ^a   Sun, Jielin ^a   Cheng, Yu ^a   Li, Ge ^a   Hsu, Fang Chi ^a   Zhu, Yi ^a   Chang, Bao Li ^a   Liu, Wennuan ^a   Kim, Jin Woo ^a   Turner, Aubrey R ^a   Gielzak, Marta ^b   Yan, Guifang ^b   Isaacs, Sarah D ^b   Wiley, Kathleen E ^b   Sauvageot, Jurga ^b   Chen, Huann Sheng ^c   Gurganus, Robin ^b   Mangold, Leslie A ^b   Trock, Bruce J ^b   Gronberg, Henrik ^d   Duggan, David ^e   Carpten, John D ^e   Partin, Alan W ^b   Walsh, Patrick C ^b   Xu, Jianfeng ^a   Isaacs, William B ^b,f   more..

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c MICHIGAN TECHNOLOGICAL UNIVERSITY   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

^e TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^f JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLELE; ARTICLE; CANCER GENETICS; CANCER PATIENT; CANCER RISK; CHI SQUARE TEST; CHROMOSOME 8Q; CHROMOSOME 8Q24; CLINICAL EVALUATION; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; DATA BASE; EUROPEAN AMERICAN; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC MARKER; GENETIC RISK; GENOTYPE; GLEASON SCORE; HEALTH CARE ORGANIZATION; HUMAN; HUMAN TISSUE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POPULATION; PRIORITY JOURNAL; PROSTATE CANCER; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; AGED; BLOOD; CANCER STAGING; CASE CONTROL STUDY; CAUCASIAN; CHROMOSOME 8; EPIDEMIOLOGY; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; MIDDLE AGED; MUTATION; ONCOGENE MYC; PATHOLOGY; PATIENT SELECTION; POLYMERASE CHAIN REACTION; PROSTATE TUMOR; RISK; RISK ASSESSMENT; STATISTICAL MODEL; UNITED STATES;

OCTAMER TRANSCRIPTION FACTOR 4; POU5F1 PROTEIN, HUMAN; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG;

AGED; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 8; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENES, MYC; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GERM-LINE MUTATION; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM STAGING; OCTAMER TRANSCRIPTION FACTOR-3; ODDS RATIO; PATIENT SELECTION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK ASSESSMENT; RISK FACTORS; SELECTION BIAS; UNITED STATES;

EID: 35548944499     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djm169     Document Type: Article

References (21)

1. Narod S. Genetic epidemiology of prostate cancer [review]. Biochim Biophys Acta 1999;1423:F1-13.
2. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, et al. Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark. Finland. N Engl J Med 2000;343:78-85.
3. Xu J, Dimitrov L, Chang B-L, Adams TS, Turner AR, Meyers DA, et al. A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics. Am J Hum Genet 2005;77:219-29.
4. Tavtigian SV, Simard J, Teng DH, Abtin V, Baumgard M, Beck A, et al. A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet 2001;27:172-80.
5. Carpten J, Nupponen N, Isaacs S, Sood R, Robbins C, Xu J, et al. Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet 2002;30:181-4.
6. Xu J, Zheng SL, Komiya A, Mychaleckyj JC, Isaacs SD, Hu JJ, et al. Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk. Nat Genet 2002;32:321-5.
7. Lindstrom S, Wiklund F, Adami HO, Balter KA, Adolfsson J, Gronberg H. Germ-line genetic variation in the key androgen-regulating genes androgen receptor, cytochrome P450, and steroid-5-alpha-reductase type 2 is important for prostate cancer development. Cancer Res 2006;66:11077-83.
8. Schaid DJ. The complex genetic epidemiology of prostate cancer. Hum Mol Genet 2004;13:R103-21.
9. Amundadottir LT, Sulem P, Gudmundsson J, Helgason A, Baker A, Agnarsson BA, et al. A common variant associated with prostate cancer in European and African populations. Nat Genet 2006;38:652-8.
10. Freedman ML, Haiman CA, Patterson N, McDonald GJ, Tandon A, Waliszewska A, et al. Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Proc Natl Acad Sci USA 2006;103:14068-73.
11. Ellwood-Yen K, Graeber TG, Wongvipat J, Iruela-Arispe ML, Zhang J, Matusik R, et al. Myc-driven murine prostate cancer shares molecular features with human prostate tumors. Cancer Cell 2003;4:223-38.
12. Suo G, Han J, Wang X, Zhang J, Zhao Y, Zhao Y, et al. Oct4 pseudogenes are transcribed in cancers. Biochem Biophys Res Commun 2005;337:1047-51.
13. Epstein JI, Allsbrook WC Jr, Amin MB, Egevad LL; ISUP Grading Committee. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 2005;29:1228-42.
14. Hoedemaeker RF, Vis AN, Van Der Kwast TH. Staging prostate cancer. Microsc Res Tech 2000;51:423-9.
15. National Institutes of Health. Cancer Genetic Markers of Susceptibility (CGEMS) study (Phase 1A). Available at: http://cgems.cancer.gov. [Last accessed: March 1, 2007.]
16. Akaike H. Information theory and an extension of the maximum likelihood principle. In: Pertaran BN, Csaaki F, editors. International Symposium on Information Theory. 2nd ed. Budapest (Hungary): Acadeemiai Kiadi; 1973. p. 267-81.
17. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002;70:425-34.
18. Takeda J, Seino S, Bell GI. Human Oct3 gene family: cDNA sequences, alternative splicing, gene organization, chromosomal location, and expression at low levels in adult tissues. Nucleic Acids Res 1992;20:4613-20.
19. Hoffmann MJ, Muller M, Engers R, Schulz WA. Epigenetic control of CTCFL/BORIS and OCT4 expression in urogenital malignancies. Biochem Pharmacol 2006;72:1577-88.
20. Loh YH, Wu Q, Chew JL, Vega VB, Zhang W, Chen X, et al. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet 2006;38:431-40.
21. Polyak K, Hahn WC. Roots and stems: stem cells in cancer. Nat Med 2006;12:296-300.